Diagnosis and Treatment
You have mild normocytic anemia of chronic kidney disease (CKD Stage 3b), severe vitamin D deficiency, and borderline low vitamin B12, requiring immediate vitamin D supplementation, consideration of iron studies, and nephrology referral for anemia management.
Primary Diagnoses
1. Anemia of Chronic Kidney Disease
Your hemoglobin of 11.9 g/dL meets criteria for anemia in the context of CKD (eGFR 47.8 mL/min = Stage 3b). The anemia is normocytic (MCV 92.5) and normochromic, which is the typical pattern for CKD-related anemia 1, 2. Anemia prevalence increases substantially when eGFR falls below 60 mL/min/1.73m², and becomes especially likely when GFR is below 30 mL/min/1.73m² 3.
The primary cause is insufficient erythropoietin production by your diseased kidneys 1, 4. However, additional workup is essential because multiple factors can contribute.
2. Severe Vitamin D Deficiency
Your vitamin D level of 8.91 ng/mL represents severe deficiency (normal >30 ng/mL). This is extremely common in CKD patients and worsens as kidney function declines 5. Vitamin D deficiency in CKD occurs because:
- Reduced endogenous synthesis in skin with declining GFR
- Increased urinary losses if you have proteinuria
- Reduced conversion to active forms by failing kidneys 5
Vitamin D deficiency is independently associated with worsening anemia and may contribute to your low hemoglobin 6, 7.
3. Borderline Low Vitamin B12
Your B12 of 265 pg/mL is in the low-normal range. While not frankly deficient, levels below 300 pg/mL can contribute to anemia, particularly in CKD 8, 9.
Required Additional Testing
Before initiating treatment, you need complete iron studies 8:
- Serum ferritin (target >100 ng/mL in non-dialysis CKD)
- Transferrin saturation (TSAT) (target >20%)
- Absolute reticulocyte count
Your ferritin of 146 ng/mL is adequate, but TSAT must be checked. Iron deficiency is present in 25-37.5% of CKD patients presenting with anemia and is a major treatable cause 1, 10. In CKD, absolute iron deficiency is defined as TSAT ≤20% with ferritin ≤100 μg/L 3, 11.
Treatment Algorithm
Immediate Actions (Start Now)
1. Vitamin D Supplementation - URGENT
- Ergocalciferol (Vitamin D2) 50,000 IU weekly for 12 weeks, then monthly maintenance 5
- This is the preferred treatment for severe deficiency in CKD
- Do NOT use calcitriol or other activated vitamin D forms for nutritional deficiency 5
- Recheck 25-hydroxyvitamin D level after 3 months
2. Vitamin B12 Supplementation
- Oral vitamin B12 1000 mcg daily
- Given your borderline level and normocytic anemia, supplementation is reasonable 8, 9
After Iron Studies Return
If TSAT ≤20% or ferritin <100 ng/mL:
- Oral iron supplementation first-line: Ferrous sulfate 325 mg daily 3, 8
- Check for gastrointestinal blood loss (stool guaiac test) as iron deficiency in CKD warrants GI evaluation 3, 1
- Recheck hemoglobin, ferritin, and TSAT in 2-3 months
If iron replete but hemoglobin remains <10 g/dL with symptoms:
- Consider erythropoiesis-stimulating agent (ESA) therapy 8
- ESA initiation should be individualized based on: rate of hemoglobin decline, symptoms (fatigue, exercise intolerance), transfusion risk, and cardiovascular history 8
- Requires nephrology management
Nephrology Referral - ESSENTIAL
You need nephrology evaluation for:
- CKD Stage 3b management and progression monitoring
- Anemia management optimization
- Assessment for other CKD complications (secondary hyperparathyroidism, metabolic acidosis)
- Determination if/when ESA therapy is appropriate
Critical Pitfalls to Avoid
Do not ignore the vitamin D deficiency - It independently worsens anemia and bone health in CKD 5, 6
Do not start ESA therapy without first optimizing iron stores - ESAs are ineffective without adequate iron availability 8
Do not use calcitriol for nutritional vitamin D deficiency - This treats secondary hyperparathyroidism, not vitamin D insufficiency 5
Do not delay nephrology referral - CKD Stage 3b with anemia requires specialist co-management 3, 2
Check for gastrointestinal bleeding if iron deficient - This is a common treatable cause in CKD patients 3, 1
Monitoring Plan
- Hemoglobin: Every 3 months initially 2
- Vitamin D: Recheck after 3 months of supplementation
- Iron studies: Recheck 2-3 months after starting iron (if deficient)
- Kidney function: Monitor creatinine/eGFR every 3-6 months
- BUN: Your elevated BUN (27) with creatinine 1.36 suggests adequate hydration but monitor for uremic symptoms
The combination of CKD-related anemia and severe vitamin D deficiency significantly impacts your quality of life, cardiovascular risk, and CKD progression 1, 4. Aggressive correction of vitamin D deficiency and optimization of iron status are evidence-based interventions that can improve your hemoglobin and slow disease progression 6, 12.